Assessing the matrix effects of hemolyzed samples in bioanalysis

Bioanalysis

Volumn 1, Issue 6, 2009, Pages 1057-1066

  Hughes, Nicola C ^a   Bajaj, Navgeet ^a   Fan, Juan ^a   Wong, Ernest Yk ^a  

^a Biovail Contract Research   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BENZODIAZEPINE DERIVATIVE; CARBAZOLE DERIVATIVE; CARVEDILOL; DRUG; HEPTANOIC ACID DERIVATIVE; OLANZAPINE; PHENYLEPHRINE; PROPANOLAMINE DERIVATIVE; PYRROLE DERIVATIVE;

ARTICLE; BLOOD; CHEMICAL ANALYSIS; ELECTROSPRAY MASS SPECTROMETRY; HEMOLYSIS; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; MICROFLUIDICS; SOLID PHASE EXTRACTION;

BENZODIAZEPINES; BLOOD; CARBAZOLES; CHEMISTRY TECHNIQUES, ANALYTICAL; CHROMATOGRAPHY, LIQUID; HEMOLYSIS; HEPTANOIC ACIDS; MICROFLUIDICS; PHARMACEUTICAL PREPARATIONS; PHENYLEPHRINE; PROPANOLAMINES; PYRROLES; SOLID PHASE EXTRACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 79953242803     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.91     Document Type: Article

References (11)

1. Kebarle P, Tang L. From ions in solution to ions in the gas phase - the mechanism of electrospray mass-spectrometry. Anal. Chem. 65, A972-A986 (1993).
2. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal Chem. 70(5), 882-889 (1998).
3. Pascoe R, Foley JP, Gusev AI. Reduction in matrix-related signal suppression effects in electrospray ionization mass spectrometry using on-line two-dimensional liquid chromatography. Anal Chem. 73(24), 6014-6023 (2001).
4. Müller C, Schäfer P, Störtzel M, Vogt S, Weinmann W. Ion suppression effects in liquid chromatography-electrosprayionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 773(1), 47-52 (2002).
5. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 852(1-2), 22-34 (2007).
6. Kang J, Hick LA, Price W. Using calibration approaches to compensate for remaining matrix effects in quantitative liquid chromatography/electrospray ionization multistage mass spectrometric analysis of phytoestrogens in aqueous environmental samples. Rapid Commun. Mass Spectrom. 21(24), 4065-4072 (2007).
7. Dams R, Huestis MA, Lambert WE, Murphy CM. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J. Am. Soc. Mass Spectrom. 14(11), 1290-1294 (2003).
8. Huynh NH, Tyrefors N, Ekman L, Johansson M. Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC-MS/MS. J. Pharm. Biomed. Anal. 37(5), 1095-1100 (2005).
9. US FDA. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2001).
10. Viswanathan CT, Bansal S, Booth B et al. Workshop/conference report - quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Am. Assoc. Pharm. Sci. J. 9(1), E30-E42 (2007).
11. Laga A, Cheves T, Maroto S, Coutts M, Sweeney J. The suitability of hemolyzed specimens for compatibility testing using automated technology. Transfusion 48(8), 1713-1720 (2008).